Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA And CMS Missions Converge In The Postmarket Arena – FDA’s Gottlieb

This article was originally published in The Gray Sheet

Executive Summary

Development of postmarket studies represents the best opportunity for CMS and FDA to collaborate and streamline the regulatory and reimbursement process, according to FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD

You may also be interested in...



HRS Moves From Successful Policy Meeting Toward Physician Guidelines

The Heart Rhythm Society hopes to complete physician guidelines on managing device safety alerts by late spring 2006, according to the chair of the committee developing the guidelines, Mark Carlson, MD, Case Western Reserve University

Acting Chief von Eschenbach Brings Zeal For Imaging To FDA

Andrew von Eschenbach's role in supporting the development of imaging and other diagnostic technology as director of the National Cancer Institute could inform his approach to medical device regulatory issues as he takes on the added role of acting FDA commissioner

CMS Will Review National Coverage Request For ICD Risk Stratification Tool

Medicare coverage of Microvolt T-Wave Alternans (MTWA)testing for ICD-eligible patients could increase the number of defibrillators implanted in patients at high risk for sudden cardiac death, according to Cambridge Heart

Related Content

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel